Skip to content

Arrow IPN030721

by Teleflex Incorporated 2 variants

Arrow IPN030721 (CS-04301-EJ) is a centrally-inserted central venous catheter (FDA Class II; FDA product code DQY, Catheter, percutaneous) made by Teleflex Incorporated, cleared under FDA 510(k) K862056 on 25 Aug 1986 and listed in FDA GUDID since 11 Aug 2020 (UDI-DI 10801902104592), active as of 23 Oct 2026. 21 FDA recalls are linked to it.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

1 ongoing

This device is named in the recall

Documents

510(k) K862056

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number10801902104592 UDI-DI Date11 Aug 2020ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Traditional NumberK862056 Date25 Aug 1986DecidedStatusActive

Official records

From the FDA record

Device description
Central Venous Catheterization Set with Blue FlexTip(R) Catheter
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
Labelled as not made with natural rubber latex
Sterility
Supplied sterile

From the GUDID record (AccessGUDID), as read on 23 Oct 2026, as the labeller entered it.

Across registries

2 registries list this device

  • FDA 510(k) K862056 decided 25 Aug 1986 Active
  • FDA GUDID UDI-DI 10801902104592 listed 11 Aug 2020 Listed

Recalls

24 recalls · 1 ongoing · FDA

    • Ongoing Z-2377-2026 FDA Class I initiated 21 Apr 2026

    Lidocaine, Bupivacaine, and 0.9% sodium chloride, the subject of a supplier recall, were included into kits and sets. The supplier was found to have quality issues and limited reports of drug ineffectiveness, and if sterility of a water-based injectable product is compromised this could lead to serious or life-threatening injuries.

  • 2 recalls, same reason

    • Terminated Z-1118-2019 FDA Class II initiated 10 Jan 2019
    • Terminated Z-1119-2019 FDA Class II initiated 10 Jan 2019

    The product lidstock contains a labelling error. The lidstock states the incorrect priming volume. The priming volumes printed on the extension lines are correct

    • Terminated Z-0723-2019 FDA Class II initiated 14 Nov 2018

    The lidstock states the incorrect priming volume and flow rates.

  • 2 recalls, same reason

    • Terminated Z-2819-2018 FDA Class II initiated 10 Jul 2018 on shared 510(k) K862056
    • Terminated Z-2818-2018 FDA Class II initiated 10 Jul 2018 on shared 510(k) K862056

    The packaging may not be sealed. If the packaging is compromised in this manner, the sterility of the product cannot be guaranteed.

    • Terminated Z-2336-2018 FDA Class II initiated 11 May 2018

    The recalling firm has received complaints related to increased resistance encountered when introducing the CVC over the spring wire guide. This may lead to procedural delay, and there may be need of medical intervention by exchanging the catheter for another CVC catheter.

  • 3 recalls, same reason

    • Terminated Z-1982-2018 FDA Class II initiated 11 Apr 2018
    • Terminated Z-1967-2018 FDA Class II initiated 11 Apr 2018
    • Terminated Z-1978-2018 FDA Class II initiated 11 Apr 2018

    Product sterility may be compromised due to unsealed packaging.

    • Terminated Z-1332-2018 FDA Class II initiated 22 Dec 2017

    Certain lots of cardiovascular catheters may not be completely sealed and so sterility of the product cannot be guaranteed.

  • 5 recalls, same reason

    • Terminated Z-0650-2018 FDA Class II initiated 17 Oct 2017
    • Terminated Z-0657-2018 FDA Class II initiated 17 Oct 2017
    • Terminated Z-0648-2018 FDA Class II initiated 17 Oct 2017
    • Terminated Z-0654-2018 FDA Class II initiated 17 Oct 2017
    • Terminated Z-0652-2018 FDA Class II initiated 17 Oct 2017

    These finished good kits may contain the incorrect Springwire Guide (SWG).

    • Terminated Z-2336-2017 FDA Class II initiated 9 May 2017

    The Arrow CVC is indicated to provide short-term (<30 days) central venous access for treatment of diseases or conditions requiring central venous access including, but not limited to: -multiple infusions of fluids, medications, or chemotherapy -infusion of fluids that are hypertonic, hyperosmolar, or have divergent pH values -frequent blood sampling or blood/blood components infusions -infusion of incompatible medications -central venous pressure monitoring lack of usable peripheral IV sites -replacement of multiple peripheral sites for IV access

    • Terminated Z-0076-2015 FDA Class II initiated 18 Sep 2014

    Arrow International, Inc. has initiated a voluntary recall for product code AK- 12703, lot number RF3039028 because the label on the outer corrugate is labeled with the incorrect expiration date. All kits packaged within the corrugate are correctly labeled. There is no risk to the patient as the kits within the corrugate are labeled with the correct expiration date.

    • Terminated Z-0066-2015 FDA Class II initiated 6 Aug 2014

    The component supplier recalled their 0.9% Sodium Chloride Injection USP BD Posiflush SF Saline Flush Syringe 10mL because some unit packages may exhibit open seals which impact package integrity and potentially product sterility.

    • Terminated Z-1965-2013 FDA Class II initiated 31 Jul 2013

    Arrow is recalling the product due to a labeling inconsistency. One portion of the lidstock states the kit contains a 3-Lumen catheter while the rest of the lidstock correctly identifies the catheter as 2-Lumen.

    • Terminated Z-0898-2011 FDA Unclassified (pre-2012) initiated 9 Nov 2010

    One lot of product was inadvertently mislabeled with a product lidstock identifying the product as a triple-lumen catheter with product number CV-15703, but a double-lumen catheter with part number CV-16702 was actually packaged in the kit.

    • Terminated Z-1653-2009 FDA Unclassified (pre-2012) initiated 17 Jun 2009

    The spring wire guide is too large in diameter to pass through the needle, dilator and catheter.

    • Terminated Z-1495-2009 FDA Unclassified (pre-2012) initiated 11 Feb 2009

    Leakage: Material not lipid resistant, may crack and/or leak. Use of this device with lipid containing solutions or 70% isopropyl alcohol may cause leakage or air embolism.

    • Terminated Z-0083-04 FDA Unclassified (pre-2012) initiated 16 Sep 2003 on shared 510(k) K862056

    wrong product in box

Recalls on a shared submission name another device cleared under the same FDA submission as this one.

Timeline

26 dated events

  1. Recall initiated FDA recalls Z-1967-2018
  2. Recall initiated FDA recalls Z-1978-2018
  3. Recall initiated FDA recalls Z-2336-2018
  4. Recall initiated FDA recalls Z-2819-2018
  5. Recall initiated FDA recalls Z-2818-2018
  6. Recall initiated FDA recalls Z-0723-2019
  7. Recall initiated FDA recalls Z-1118-2019
  8. Recall initiated FDA recalls Z-1119-2019
  9. Listed FDA GUDID 10801902104592
  10. Recall initiated FDA recalls Z-2377-2026

16 earlier events are in the sections above.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
Arrow
Generic name
Centrally-inserted central venous catheter
Model / Ref / Catalog
IPN030721, CS-04301-EJ
Primary DI / UDI-DI
10801902104592
510(k) Number
FDA product code
DQY
GMDN term
Centrally-inserted central venous catheter
Device class
Class II
Regulation number
870.1250
GUDID distribution status
In Commercial Distribution

Similar devices in this category

Other devices filed under Centrally-inserted central venous catheter.

Other devices from Teleflex Incorporated

  • Arrow IPNB00820 Open recall

    Class II
  • Arrow IPNB00826 Open recall

    Class II
  • Arrow IPNB00822 Open recall

    Class II
  • Arrow IPNB00827 Open recall

    Class II

See all devices from Teleflex Incorporated →

Properties

  • Supplied sterile
  • Single use
  • Implantable
  • Prescription use
  • Convenience kit
  • Lot / batch number
  • Expiration date
Other properties (8, all answered No)